Clinical Other

Neuro-Ophthalmology

Neuro-Ophthalmology

What You'll Learn

  • Pupil-involving CN III palsy: PComm aneurysm until proven otherwise — pupil fibers travel superficially on CN III, compressed by aneurysm before microvascular ischemia reaches them
  • RAPD: localizes to optic nerve (or massive retinal disease) — NEVER caused by cataracts, refractive error, or media opacity
  • INO: MLF lesion → ipsilateral adduction deficit + contralateral abducting nystagmus; young bilateral = MS, old unilateral = stroke
  • GCA: start glucocorticoids BEFORE temporal artery biopsy. Use IV pulse methylprednisolone for threatened vision loss / cranial ischemia; high-dose oral prednisone is standard for active GCA without cranial ischemia (per 2021 ACR/VF). Jaw claudication is the most specific symptom.
  • ONTT: low-dose oral prednisone alone increases optic neuritis recurrence — do not use. High-dose oral corticosteroids bioequivalent to IV methylprednisolone have similar short-term outcomes in typical ON (modern data).
  • Horner syndrome + ipsilateral pain: carotid dissection until proven otherwise (3rd-order neuron)
  • Visual field defects: more congruous = more posterior; macular sparing = occipital lobe (best explained by bilateral cortical representation + large cortical magnification of the macula; the classical "dual PCA/MCA blood supply" teaching is not well supported by anatomic data)
HighYield Pearls
  • Pupil-involving CN III palsy: PComm aneurysm → urgent CTA/angiography; SAH risk — never call it microvascular until imaging is clean
  • Painful Horner + neck pain: carotid dissection until proven otherwise → urgent CTA neck/MRA; apraclonidine reverses anisocoria to confirm Horner
  • Suspected GCA: start glucocorticoids immediately BEFORE temporal artery biopsy — IV pulse methylprednisolone for threatened vision/cranial ischemia, high-dose oral prednisone for active GCA without cranial ischemia (2021 ACR/VF). Tocilizumab is steroid-sparing; fellow eye blinds within days if untreated
  • Optic neuritis (ONTT): IV methylprednisolone speeds recovery and delays MS conversion at 2 yr; low-dose oral prednisone alone (as used in ONTT) INCREASES recurrence — do not use. High-dose oral corticosteroids bioequivalent to IV MP have similar short-term outcomes.
  • Atypical ON (bilateral, severe, painless, recurrent, NLP) → send AQP4-IgG and MOG-IgG; treat as NMOSD until proven otherwise (plasma exchange if steroid-refractory)
  • Bilateral INO in a young patient: MS until proven otherwise; unilateral INO in older vasculopath → brainstem stroke
  • Vertical supranuclear gaze palsy + preserved VOR (doll’s eyes): PSP — downgaze affected first; pair with axial rigidity and early falls
  • Spasmus nutans (child: head bobbing + nystagmus + torticollis) → MRI to rule out chiasm/hypothalamic glioma — do NOT call it benign without imaging
  • IIH with vision threat: escalate beyond acetazolamide — ONSF, CSF shunt, or venous sinus stenting; transient visual obscurations & enlarging blind spot are red flags
  • Foster Kennedy syndrome (unilateral optic atrophy + contralateral papilledema) → frontal mass (olfactory groove meningioma) until imaged
  • Ocular myasthenia: fatigable ptosis + variable diplopia, normal pupils; ice pack test improves ptosis; check anti-AChR and screen for thymoma
🔍 Quick ReferenceClinical · Visual field / pupils / gaze · Workup / treatment
Clinical phenotype
  • Painful monocular vision loss + red desaturation in a young womanoptic neuritis (MS)
  • Jaw claudication + scalp tenderness + new headache age >50 + chalky-white swollen discarteritic AION (GCA)
  • Vasculopath wakes with altitudinal field defect + crowded "disc at risk"NAION
  • Young male, bilateral subacute painless central vision loss + telangiectatic peripapillary microangiopathy + maternal inheritanceLHON (m.11778G>A)
  • Down-and-out eye with dilated pupil after sudden headachePComm aneurysm CN III palsy
  • Vertical diplopia worse going downstairs + compensatory head tiltCN IV (trochlear) palsy
  • Proptosis + lid lag + EOM enlargement sparing tendon insertionsthyroid (Graves) ophthalmopathy
  • Fatigable ptosis + Cogan twitch + ice-pack improvementocular myasthenia gravis
  • Obese young woman + headache + pulsatile tinnitus + transient visual obscurationsidiopathic intracranial hypertension
Pupil / VF / gaze findings
  • RAPD (Marcus-Gunn pupil) + central scotomaoptic nerve lesion (ON/AION)
  • Mild ptosis + miosis + anhidrosisHorner syndrome (painful + neck → carotid dissection)
  • Dilated pupil + sluggish to light + brisk to near + slow redilation + tendon areflexiaAdie tonic pupil (Holmes-Adie)
  • Small irregular pupils that accommodate but do not react ("prostitute pupil")Argyll Robertson (neurosyphilis / DM)
  • Ipsilateral adduction failure + contralateral abducting nystagmus + preserved convergenceINO (MLF lesion)
  • Ipsilateral conjugate gaze palsy + ipsilateral INOone-and-a-half syndrome (paramedian pontine + MLF)
  • Vertical supranuclear gaze palsy with intact VOR/doll’s eyesPSP
  • Homonymous hemianopia with macular sparingoccipital cortex (PCA) stroke
  • "Pie in the sky" superior quadrantanopiatemporal lobe (Meyer loop); "pie on the floor"parietal optic radiations
  • Bitemporal hemianopiachiasm (pituitary adenoma / craniopharyngioma); junctional scotomaanterior chiasm / distal optic nerve
  • Downbeat nystagmuscervicomedullary junction (Chiari, MS, lithium/AED toxicity); upbeatbrainstem
  • Pendular nystagmus + palatal tremoroculopalatal myoclonus (hypertrophic olivary degeneration / Mollaret triangle)
  • See-saw nystagmusparasellar / chiasmal lesion; periodic alternating nystagmuscerebellar (nodulus/uvula)
  • Unilateral optic atrophy + contralateral papilledemaFoster Kennedy syndrome (frontal mass)
  • Cortical blindness + denial/confabulationAnton syndrome (bilateral occipital); simultanagnosia + optic ataxia + ocular apraxiaBalint (bilateral parieto-occipital watershed)
Workup / treatment
  • ESR ≥50, CRP elevated, platelets ≥400K in patient >50 with new visual lossstart glucocorticoids immediately (IV pulse methylprednisolone if vision threatened / cranial ischemia; otherwise high-dose oral prednisone), then temporal artery biopsy
  • Apraclonidine reverses anisocoria (dilates the miotic pupil)confirms Horner syndrome
  • Low-dose pilocarpine (0.125%) constricts a dilated tonic pupildenervation supersensitivity — Adie pupil
  • AQP4-IgG serum (cell-based assay)NMOSD; MOG-IgG serumMOGAD; oligoclonal bands → MS
  • MRI orbits with fat suppression + gadoliniumoptic neuritis (short-segment enhancement = MS; long-segment/perineural = MOGAD; chiasmal = NMOSD)
  • LP opening pressure >25 cm H₂O with normal CSF in obese young womanIIH → acetazolamide + topiramate + weight loss; ONSF / CSF shunt / venous stenting for vision threat
  • Empty sella, posterior globe flattening, distended optic nerve sheath, transverse sinus stenosis on MRVIIH imaging signature
  • Pupil-involving CN III palsyurgent CTA / catheter angiogram for PComm aneurysm
  • Anti-AChR / anti-MuSK + chest CT for thymoma; ice pack + edrophonium (historical)ocular myasthenia workup; treat with pyridostigmine ± steroids
  • RPR/VDRL + FTA-ABS + CSF VDRLArgyll Robertson / neurosyphilis
  • Mitochondrial DNA testing (m.11778G>A, m.14484T>C, m.3460G>A)LHON; idebenone trialed
Optic Neuritis

Typical vs Atypical Optic Neuritis

FeatureTypical ON (MS-associated)Atypical ON
Age20–45 yearsAny age (children, >50)
PainPeriorbital, worse with eye movement (92%)May be painless or severe
Vision lossMild–moderate; central scotomaSevere (NLP possible in NMOSD)
LateralityUnilateralBilateral (NMOSD, MOGAD, sarcoid)
Disc appearance66% retrobulbar (normal disc); 33% disc edemaDisc edema more common (MOGAD, NMOSD)
RecoveryGood (>90% recover to 20/40 by 1 year)Poor recovery (NMOSD); good in MOGAD
MRI orbitsShort-segment enhancement (<50% nerve length)Long-segment or perineural enhancement
Key associationsMS (50% develop MS within 15 yr)NMOSD, MOGAD, sarcoid, syphilis, lupus

MS vs NMOSD vs MOGAD Optic Neuritis

FeatureMSNMOSD (AQP4+)MOGAD
SeverityMild–moderateSevere (often ≤20/200)Moderate–severe
BilateralRare (unilateral)Simultaneous or sequential bilateralOften bilateral (especially children)
Disc edemaUncommon (retrobulbar)CommonVery common (prominent edema)
Enhancement patternShort segment, no perineuralPosterior/chiasmal involvementAnterior, long segment, perineural sheath
RecoveryExcellentPoor without treatmentExcellent (often complete)
RecurrenceCommonVery common (attack-driven damage)Common; relapsing form exists
OCT (RNFL)Mild thinningSevere thinningVariable
AntibodyOligoclonal bands (CSF)AQP4-IgG (serum)MOG-IgG (serum)

Treatment — ONTT Key Findings

  • IV methylprednisolone (3 days) → oral taper: faster recovery; no difference in final visual outcome at 1 year
  • Low-dose oral prednisone alone (as used in ONTT): INCREASED recurrence rate — should not be used. High-dose oral corticosteroids bioequivalent to IV methylprednisolone have similar short-term outcomes in typical optic neuritis.
  • Observation: acceptable for mild cases; equivalent long-term visual outcome to IV steroids
  • MS risk: ≥1 brain MRI lesion at presentation → 72% MS risk at 15 yr; 0 lesions → 25%
💎 Board Pearl
  • ONTT: low-dose oral prednisone alone increases recurrence — the #1 tested fact from this trial. High-dose oral corticosteroids bioequivalent to IV MP are acceptable (similar short-term outcomes).
  • RAPD is the hallmark of optic neuritis — if absent, reconsider the diagnosis
  • Uhthoff phenomenon: transient visual worsening with heat/exercise (demyelinated nerve conducts worse when warm)
🔒

Continue reading — sign in

The full note has more clinical pearls, tables, and board-focused tips. Free account, no fee.